Literature DB >> 17539621

Synthesis of stable and potent delta/mu opioid peptides: analogues of H-Tyr-c[D-Cys-Gly-Phe-D-Cys]-OH by ring-closing metathesis.

Adriano Mollica1, Giovanni Guardiani, Peg Davis, Shou-Wu Ma, Frank Porreca, Josephine Lai, Luisa Mannina, Anatoli P Sobolev, Victor J Hruby.   

Abstract

Ring-closing metathesis has emerged as a powerful tool in organic synthesis for generating cyclic structures via C-C double bond formation. Recently, it has been successfully used in peptide chemistry for obtaining cyclic molecules bridged through an olefin unit in place of the usual disulfide bond. Here, we describe this approach for obtaining cyclic olefin bridged analogues of H-Tyr-c[D-Cys-Gly-Phe-Cys]-OH. The synthesis of the new ligands was performed using the second generation Grubbs' catalyst. The resulting cis-8 (cDADAE) and trans-9 (tDADAE) were fully characterized and tested at delta, mu, and kappa opioid receptors. Also the linear precursor 13 (lDADAE) and the hydrogenated derivative 11 (rDADAE) also were tested. All the cyclic products containing a olefinic bond are slightly selective but highly active and potent for the delta and mu opioid receptors. Activity toward the kappa opioid receptors was absent or very low.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17539621      PMCID: PMC2274921          DOI: 10.1021/jm061048b

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  31 in total

1.  The development of L2X2Ru=CHR olefin metathesis catalysts: an organometallic success story.

Authors:  T M Trnka; R H Grubbs
Journal:  Acc Chem Res       Date:  2001-01       Impact factor: 22.384

Review 2.  Cyclization strategies in peptide derived drug design.

Authors:  Peng Li; Peter P Roller
Journal:  Curr Top Med Chem       Date:  2002-03       Impact factor: 3.295

3.  Synthesis of trisubstituted alkenes via olefin cross-metathesis.

Authors:  A K Chatterjee; R H Grubbs
Journal:  Org Lett       Date:  1999-12-02       Impact factor: 6.005

4.  Ring substituted and other conformationally constrained tyrosine analogues of [D-Pen2,D-Pen5]enkephalin with delta opioid receptor selectivity.

Authors:  G Toth; K C Russell; G Landis; T H Kramer; L Fang; R Knapp; P Davis; T F Burks; H I Yamamura; V J Hruby
Journal:  J Med Chem       Date:  1992-06-26       Impact factor: 7.446

5.  Synthesis and activity of a new generation of ruthenium-based olefin metathesis catalysts coordinated with 1,3-dimesityl-4,5-dihydroimidazol-2-ylidene ligands.

Authors:  M Scholl; S Ding; C W Lee; R H Grubbs
Journal:  Org Lett       Date:  1999-09-23       Impact factor: 6.005

6.  Stereochemical control of peptide folding.

Authors:  R Kaul; P Balaram
Journal:  Bioorg Med Chem       Date:  1999-01       Impact factor: 3.641

7.  Pronociceptive actions of dynorphin maintain chronic neuropathic pain.

Authors:  Z Wang; L R Gardell; M H Ossipov; T W Vanderah; M B Brennan; U Hochgeschwender; V J Hruby; T P Malan; J Lai; F Porreca
Journal:  J Neurosci       Date:  2001-03-01       Impact factor: 6.167

8.  A frame shifted disulfide bridged analogue of angiotensin II.

Authors:  Boris Schmidt; Christian Kühn; Dennis K Ehlert; Gunnar Lindeberg; Susanna Lindman; Anders Karlén; Anders Hallberg
Journal:  Bioorg Med Chem       Date:  2003-03-20       Impact factor: 3.641

9.  (2S,3R) beta-methyl-2',6'-dimethyltyrosine-L-tetrahydroisoquinoline-3-carboxylic acid [(2S,3R)TMT-L-Tic-OH] is a potent, selective delta-opioid receptor antagonist in mouse brain.

Authors:  Keiko Hosohata; Eva V Varga; Josue Alfaro-Lopez; Xuejun Tang; Todd W Vanderah; Frank Porreca; Victor J Hruby; William R Roeske; Henry I Yamamura
Journal:  J Pharmacol Exp Ther       Date:  2003-02       Impact factor: 4.030

10.  Synthesis of biologically active dicarba analogues of the peptide hormone oxytocin using ring-closing metathesis.

Authors:  Jake L Stymiest; Bryan F Mitchell; Susan Wong; John C Vederas
Journal:  Org Lett       Date:  2003-01-09       Impact factor: 6.005

View more
  16 in total

1.  Strategies for recognition of stem-loop RNA structures by synthetic ligands: application to the HIV-1 frameshift stimulatory sequence.

Authors:  Prakash B Palde; Leslie O Ofori; Peter C Gareiss; Jaclyn Lerea; Benjamin L Miller
Journal:  J Med Chem       Date:  2010-08-26       Impact factor: 7.446

Review 2.  Peptidomimetics, a synthetic tool of drug discovery.

Authors:  Josef Vagner; Hongchang Qu; Victor J Hruby
Journal:  Curr Opin Chem Biol       Date:  2008-05-14       Impact factor: 8.822

3.  Biological active analogues of the opioid peptide biphalin: mixed α/β(3)-peptides.

Authors:  Adriano Mollica; Francesco Pinnen; Roberto Costante; Marcello Locatelli; Azzurra Stefanucci; Stefano Pieretti; Peg Davis; Josephine Lai; David Rankin; Frank Porreca; Victor J Hruby
Journal:  J Med Chem       Date:  2013-04-12       Impact factor: 7.446

4.  Novel cyclic biphalin analogue with improved antinociceptive properties.

Authors:  Adriano Mollica; Alfonso Carotenuto; Ettore Novellino; Antonio Limatola; Roberto Costante; Francesco Pinnen; Azzurra Stefanucci; Stefano Pieretti; Anna Borsodi; Reza Samavati; Ferenc Zador; Sándor Benyhe; Peg Davis; Frank Porreca; Victor J Hruby
Journal:  ACS Med Chem Lett       Date:  2014-07-14       Impact factor: 4.345

5.  Design, synthesis, and opioid activity of arodyn analogs cyclized by ring-closing metathesis involving Tyr(allyl).

Authors:  Wei-Jie Fang; Thomas F Murray; Jane V Aldrich
Journal:  Bioorg Med Chem       Date:  2017-11-21       Impact factor: 3.641

6.  The cis-4-amino-L-proline residue as a scaffold for the synthesis of cyclic and linear endomorphin-2 analogues.

Authors:  Adriano Mollica; Francesco Pinnen; Azzurra Stefanucci; Federica Feliciani; Cristina Campestre; Luisa Mannina; Anatoly P Sobolev; Gino Lucente; Peg Davis; Josephine Lai; Shou-Wu Ma; Frank Porreca; Victor J Hruby
Journal:  J Med Chem       Date:  2012-03-22       Impact factor: 7.446

7.  Cyclic enkephalins with a diversely substituted guanidine bridge or a thiourea bridge: synthesis, biological and structural evaluations.

Authors:  Engin Bojnik; Baptiste Legrand; Youness Touati-Jallabe; Elodie Mauchauffée; Nga N Chung; Peter W Schiller; Sandor Benyhe; Marie-Christine Averlant-Petit; Jean Martinez; Jean-Franćois Hernandez
Journal:  J Med Chem       Date:  2013-07-12       Impact factor: 7.446

8.  Opioid Receptor Activity and Analgesic Potency of DPDPE Peptide Analogues Containing a Xylene Bridge.

Authors:  Azzurra Stefanucci; Ettore Novellino; Sako Mirzaie; Giorgia Macedonio; Stefano Pieretti; Paola Minosi; Edina Szűcs; Anna I Erdei; Ferenc Zádor; Sándor Benyhe; Adriano Mollica
Journal:  ACS Med Chem Lett       Date:  2017-03-14       Impact factor: 4.345

9.  Cyclic opioid peptide agonists and antagonists obtained via ring-closing metathesis.

Authors:  Irena Berezowska; Carole Lemieux; Nga N Chung; Brian C Wilkes; Peter W Schiller
Journal:  Chem Biol Drug Des       Date:  2009-08-20       Impact factor: 2.817

10.  Design, synthesis, and pharmacological activities of dynorphin A analogues cyclized by ring-closing metathesis.

Authors:  Wei-Jie Fang; Yanjun Cui; Thomas F Murray; Jane V Aldrich
Journal:  J Med Chem       Date:  2009-09-24       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.